Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 2,560.73 million compared to INR 3,724.34 million a year ago. Revenue was INR 2,579.65 million compared to INR 3,740.47 million a year ago. Net income was INR 34.14 million compared to INR 73 million a year ago. Basic earnings per share from continuing operations was INR 1.34 compared to INR 2.88 a year ago. Diluted earnings per share from continuing operations was INR 1.34 compared to INR 2.88 a year ago.